These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 25656996)
1. Diazeniumdiolation of protamine sulfate reverses mitogenic effects on smooth muscle cells and fibroblasts. van Lith R; Yang J; Ameer GA Free Radic Biol Med; 2015 May; 82():13-21. PubMed ID: 25656996 [TBL] [Abstract][Full Text] [Related]
2. Role of redox signaling and poly (adenosine diphosphate-ribose) polymerase activation in vascular smooth muscle cell growth inhibition by nitric oxide and peroxynitrite. Huang J; Lin SC; Nadershahi A; Watts SW; Sarkar R J Vasc Surg; 2008 Mar; 47(3):599-607. PubMed ID: 18295111 [TBL] [Abstract][Full Text] [Related]
3. Diazeniumdiolated carbamates: a novel class of nitric oxide donors. Nandurdikar RS; Maciag AE; Cao Z; Keefer LK; Saavedra JE Bioorg Med Chem; 2012 Mar; 20(6):2025-9. PubMed ID: 22356735 [TBL] [Abstract][Full Text] [Related]
4. Antioxidants modulate the antiproliferative effects of nitric oxide on vascular smooth muscle cells and adventitial fibroblasts by regulating oxidative stress. Gregory EK; Vavra AK; Moreira ES; Havelka GE; Jiang Q; Lee VR; Van Lith R; Ameer GA; Kibbe MR Am J Surg; 2011 Nov; 202(5):536-40. PubMed ID: 21944289 [TBL] [Abstract][Full Text] [Related]
5. Hybrid molecule from O2-(2,4-dinitrophenyl)diazeniumdiolate and oleanolic acid: a glutathione S-transferase π-activated nitric oxide prodrug with selective anti-human hepatocellular carcinoma activity and improved stability. Fu J; Liu L; Huang Z; Lai Y; Ji H; Peng S; Tian J; Zhang Y J Med Chem; 2013 Jun; 56(11):4641-55. PubMed ID: 23617697 [TBL] [Abstract][Full Text] [Related]
7. Protein kinase G activity prevents pathological-level nitric oxide-induced apoptosis and promotes DNA synthesis/cell proliferation in vascular smooth muscle cells. Wong JC; Fiscus RR Cardiovasc Pathol; 2010; 19(6):e221-31. PubMed ID: 20060325 [TBL] [Abstract][Full Text] [Related]
8. Permeability changes in response to NONOate and NONOate prodrug derived nitric oxide in a blood-brain barrier model formed by primary porcine endothelial cells. Winter S; Konter J; Scheler S; Lehmann J; Fahr A Nitric Oxide; 2008 May; 18(3):229-39. PubMed ID: 18284923 [TBL] [Abstract][Full Text] [Related]
9. Nitric oxide-producing polyurethanes. Jun HW; Taite LJ; West JL Biomacromolecules; 2005; 6(2):838-44. PubMed ID: 15762649 [TBL] [Abstract][Full Text] [Related]
10. NG as a novel nitric oxide donor induces apoptosis by increasing reactive oxygen species and inhibiting mitochondrial function in MGC803 cells. Liu L; Li T; Tan J; Fu J; Guo Q; Ji H; Zhang Y Int Immunopharmacol; 2014 Nov; 23(1):27-36. PubMed ID: 25135879 [TBL] [Abstract][Full Text] [Related]
11. Second-generation aspirin and indomethacin prodrugs possessing an O(2)-(acetoxymethyl)-1-(2-carboxypyrrolidin-1-yl)diazenium-1,2-diolate nitric oxide donor moiety: design, synthesis, biological evaluation, and nitric oxide release studies. Velázquez CA; Chen QH; Citro ML; Keefer LK; Knaus EE J Med Chem; 2008 Mar; 51(6):1954-61. PubMed ID: 18314945 [TBL] [Abstract][Full Text] [Related]
12. Diazen-1-ium-1,2-diolated nitric oxide donor ester prodrugs of 5-(4-carboxymethylphenyl)-1-(4-methanesulfonylphenyl)-3-trifluoromethyl-1H-pyrazole and its aminosulfonyl analog: Synthesis, biological evaluation and nitric oxide release studies. Abdellatif KR; Chowdhury MA; Dong Y; Das D; Yu G; Velázquez C; Suresh MR; Knaus EE Bioorg Med Chem; 2009 Jul; 17(14):5182-8. PubMed ID: 19500994 [TBL] [Abstract][Full Text] [Related]
13. Hybrid Nitric Oxide Donor and its Carrier for the Treatment of Peripheral Arterial Diseases. Le DQ; Kuriakose AE; Nguyen DX; Nguyen KT; Acharya S Sci Rep; 2017 Aug; 7(1):8692. PubMed ID: 28821752 [TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and biological evaluation of novel nitric oxide donors with antioxidative activity. Liang J; Zhang P; Yang H; Zhang Y; Yao T; Liu K; Wang Y; Zhang X; Qin X Eur J Med Chem; 2022 Jun; 236():114331. PubMed ID: 35421659 [TBL] [Abstract][Full Text] [Related]
15. Protective effects of novel metal-nonoates on the cellular components of the vascular system. Monti M; Solito R; Puccetti L; Pasotti L; Roggeri R; Monzani E; Casella L; Morbidelli L J Pharmacol Exp Ther; 2014 Dec; 351(3):500-9. PubMed ID: 25238748 [TBL] [Abstract][Full Text] [Related]
16. Methylglyoxal-induced nitric oxide and peroxynitrite production in vascular smooth muscle cells. Chang T; Wang R; Wu L Free Radic Biol Med; 2005 Jan; 38(2):286-93. PubMed ID: 15607912 [TBL] [Abstract][Full Text] [Related]
17. New stent surface materials: the impact of polymer-dependent interactions of human endothelial cells, smooth muscle cells, and platelets. Busch R; Strohbach A; Rethfeldt S; Walz S; Busch M; Petersen S; Felix S; Sternberg K Acta Biomater; 2014 Feb; 10(2):688-700. PubMed ID: 24148751 [TBL] [Abstract][Full Text] [Related]
18. Nitric oxide activates PI3-K and MAPK signalling pathways in human and rat vascular smooth muscle cells: influence of insulin resistance and oxidative stress. Doronzo G; Viretto M; Russo I; Mattiello L; Di Martino L; Cavalot F; Anfossi G; Trovati M Atherosclerosis; 2011 May; 216(1):44-53. PubMed ID: 21316056 [TBL] [Abstract][Full Text] [Related]